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Abstract 
Thyroxin has been shown to have a beneficial effect on renal function in cases of 
pending renal failure in animal studies•-s. Studies of the use of thyroxin in humans in 
pending renal failure are scarce. The aim of this study was to assess the effect of oral 
thyroxin on the renal function of asphyxiated neonates who often have renal 
impairment. 
A randomised controlled trial was conducted. Two groups of 15 term asphyxiated 
neonates were studied. Thyroxin (50 Jlg) was given on day 1, 2 and 3 of life for the 
treatment group and placebo was given for the control group. Renal function was 
studied on day 1 and day 4 of life 
The two groups were not statistically significant different for gestational age, 
birthweight, severity of asphyxia, pregnancy or delivery complications, fluids 
administered and drugs used. There was no significant difference in urine output, 
creatinin clearance and fractional excretion of sodium on day 1 but there was a trend 
towards a worse renal function on day 1 in the treatment group. The creatinin 
clearance (Clcreat) was significantly better in the treatment group on day 4 (p = 0.017). 
Urine output and fractional excretion of sodium on day 4 were better in the treatment 
group but the differences did not reach statistical significance (p of 0.14 and 0.057 
respectively). Statistical analysis on the differences between day 4 and day 1 showed 
statistical significance only for Clcreat : Clcreat day 4 - Clcreat day 4 was 52.6 ( +/-
32.4)for the thyroxin group and 7.3 ( +/- 7.8)for the controls (p= 0.006). 
These data support that thyroxin may have a significant beneficial effect on the renal 
function in patients with perinatal asphyxia. Thyroxin may be proven useful in future 
for patients with pending renal failure. 
Introduction 
Birth asphyxia and kidney function : 
Birth asphyxia remains one of the major perinatal problems. Neurological sequelae 
can be extensive and care of the new-born with asphyxia is primarily directed towards 
a reduction in the neurological morbidity. However the brain is not the only organ 
affected by asphyxia. There is often a significant degree of other organ involvement6 : 
asphyxiated babies have often multiple organ failure. Organs, other than the brain 
which are most frequently affected are the kidneys, the gastro intestinal tract 
(necrotising enterocolitis, transient rise in liver enzymes),the heart and the lungs. 
The kidney function has been studied in asphyxiated neonates. Up to over 40 percent 
of children with perinatal asphyxia have renal impairment6•7 and almost all of the 
severe cases. Generally the medulla is the first affected since that part of the kidney 
has under normal conditions a very limited blood supply. Tubular dysfunction is a 
consequence of this medullar hypoxia, often presenting as problems with sodium 
reabsorption. 
This kind of tubular dysfunction may also have its effects on the glomerular function 
resulting in a decrease in glomerular filtration rate (tubulo-glomerular feedback). A 
good estimate of the glomerular filtration rate can be made by measuring the creatinin 
clearance. 
As a result of this combined glomerular and tubular dysfunction, the urine output is 
generally low in the first few days of life of asphyxiated children. 
Most authors however found that the impairment of renal function is transient in most 
cases. However azothaemia and disturbances of the fluid balance could aggravate the 
cerebral damage, which is the main determinant of the final outcome for the patient. 
Thyroxin and acute or impending acute renal failure: 
Thyroxin has been proven in several animal studies to be effective in treating and 
reverting pending acute renal failure. There are several papers detnonstrating renal 
protective effects of thyroxin administered to animals with experimentally induced 
nephrotoxic (gentamicin, uranyl nitrate, ... ) renal failure14• 
Further animal studies 4•5 have been reported, using hypoxic ischaemic models of acute 
renal failure and each of those studies was capable of demonstrating a positive effect 
of thyroxin on renal function. Some of them used daily doses for several days, others 
were using a single dose at the moment of maximal expected renal injury. The renal 
function was improving in terms of urine output, glomerular filtration rate and urinary 
fractional sodium reabsorption. 
Human studies on the use of thyroxin in acute or pending acute renal failure are quite 
scarce. Straub has reported a few uncontrolled studies8'9 on the use of thyroxin in 
children with renal failure, mentioning resumption of urine output in all studied 
subjects within two days of thyroxin administration. There is one study10 reporting a 
randomised controlled trial of thyroxin therapy in babies with asphyxia. This study 
was showing a beneficial effect of thyroxin on glomerular filtration rate and tubular 
function. 
Aim of this study 
The aim of this study was to evaluate the effect of thyroxin on the renal function in 
asphyxiated term neonates. 
Materials and methods 
A placebo controlled randomised trial was conducted .. 
Subjects 
Two groups of 15 term asphyxiated neonates were studied. The patients were 
allocated to one group or the other according to a computer generated random table. 
Asphyxia was defined as having an Apgar score at 5 minutes of less than 7 and a first 
pH showing a bicarbonate level of less than 18 mmol I litre. Only term babies were 
included in the study (babies born with gestational age of38-42 weeks). Babies with 
congenital abnormalities were excluded from the study. 
Methods 
The babies in the treatment group received 50 Jlg of thyroxin (crushed tablet mixed 
with I cc of water for injection through Riles tube) on day 1,2 and 3. The babies in the 
~ 
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control group received placebo (glucose) in a similar way. 
Complications during pregnancy and delivery were recorded in a standardised way. 
The clinical condition of the baby and postnatal complications and therapies provided 
were similarly recorded 
Renal function was measured on day 1 and day 4 of life of the babies included in the 
study. Urine output was expressed in mllkglh. Electrolytes (Na, K, Ca, P and Mg),. 
urea and creatinine were measured in serum and urine. From these values creatinine 
clearances and fractional excretions were calculated using standardised formulas. 
The results were computed and processed with Epi-info and Kruskal Willis H. test 
was used for statistical analysis. 
Results. 
Treatment group and control group did not differ significantly for the baseline 
characteristics of the patients in each of the groups. The number and severity of 
complications during pregnancy and delivery were similar for both groups. The 
distribution of the mode of delivery was also comparable for both groups. The 
gestational age, birth weight, sex, parameters correlating with the severity of asphyxia 
and the mean BP on day 1 were also comparable 
There were also no significant differences in fluid management or drug therapy 
between the 2 groups. 
The results of the renal function tests are given in table I. 
There was no significant difference between the 2 groups for urine output, creatinin 
clearance and fractional excretion (FE) of sodium on day I but there was a trend 
towards a worse renal function in the treatment group. The creatinin clearance was 
significantly better in the treatment group on day 4 (p = 0.017). Urine output and 
fractional excretion of sodium on day 4 were better in the treatment group but the 
differences did not reach statistical significance (p of 0.14 and 0.057 respectively). 
When the differences between day 4 and day 1 within the same group were compared 
for the tested parameters, statistical significance was only found for the creatinin 
clearance (Clcreat) : Clcreat day 4 - Clcreat day 1 was 52.6 (+/-32.4)for the thyroxin group 
and 7.3 (+/- 7.8)for the controls (p= 0.006) 
thyroxin (n) SD placebo (n) SD p value 
Cl creat day 1/1.73m 2 5.55 mVmin (8) 3.4 12.6 ml/min (10) 10.0 0.13 
Cl creat day 4/1.73m2 58.38 mVmin (8) 34.6 17.4 mVmin (8) 14.09 0.017 
Urine output day 1 0. 7 mllkg/h (II) 0.5 1.2 mllkglh (13) 0.9 0.14 
Urine output day 4 2.4 ml/kg/h (I 0) 0.3 I .8 ml/kg/h (8) 0.5 0.070 
FE Naday 1 2.0% (9) 2.4 1.9% (II) 2.06 0.96 
FE Naday4 0.4% (7) 0.4 1.2% (8) 0.9 0.056 
Table 1 : renal function parameters on day I and on day 4 
Due to technical problems such as not enough blood in the sample, problems with 
urine collection or laboratory factors not every patient in this study got full results for 
every parameter. The number of observations for each parameter within each group is 
indicated between brackets (n). 
Discussion 
The results of this study are suggesting that thyroxin is capable of improving renal 
function in neonates suffering from asphyxia 
The urine output is considerably less (but not statistically significant) in the treatment 
group on day 1 than in the control group. However on day four the urine output is a lot 
better in the treatment group when compared to the control group, just not reaching 
significance. Similarly the creatinin clearance is lower in the treatment group than in 
the control group on day 1 (not significant) but on day four it is significantly better for 
the treatment group than for the control group. 
The fractional excretion of sodium can be seen as a parameter for assessing the 
tubular functions. There was no difference on day one but on day four there was a 
clear trend towards a lower fractional excretion of sodium and thus a better tubular 
function on day four in the treatment group. 
The relatively high standard deviations may be due to the relatively small number of 
observations. Larger studies may prove more convincingly the effect of thyroxin on 
renal function in asphyxiated subjects. 
Asphyxiated neonates can be considered to be in impending acute renal failure and, as 
in previous studies also demonstrated, thyroxin may prevent the development to overt 
acute renal failure. The mechanism of action of thyroxin on the kidney has been 
studied as well. In studies where the renal cortical sodium-potassium A TP-ase was 
measured, there was a very marked increase in activity of this enzyme in the renal 
tubular cells. 
This effect of thyroxin on the sodium-potassium ATP-ase, maybe mediated by effects 
on alkaline and acid phosphatases, is assumed to be responsible for the positive effects 
of thyroxin on renal function. This increase in sodium-potassium ATP-ase results in 
an increase in tubular reabsorption of sodium in the proximal tubules, thus restoring 
the main function of the proximal tubuli6• Through the mechanism oftubulo-
glomerular feedback the glomerular filtration increases subsequently as well. 
Conclusion 
This study suggest that thyroxin has a positive effect on renal function in asphyxiated 
neonates. Other studies have shown similar effects on renal function in patients with 
impending renal failure. 
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